Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: Florida investor Danny Gaekwad offers competing bid for Religare takeover.
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
Search
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Religare takeover intensifies: Florida investor Danny Gaekwad makes competing bid
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > Florida investor Danny Gaekwad offers competing bid for Religare takeover.
Economy

Florida investor Danny Gaekwad offers competing bid for Religare takeover.

January 25, 2025 2 Min Read
Share
SHARE

A new development has emerged in the ongoing Religare Enterprises’ (REL) takeover saga, with Florida-based businessman Danny Gaekwad expressing interest in making a competing offer in cash for REL at ₹275 per share. This offer contrasts with the ₹235 per share bid made by the Burman Family entities of the Dabur Group in the Open Offer scheduled to begin on Monday.

In a letter addressed to the SEBI Chairperson dated January 24, investor Digvijay Laxhamsingh Gaekwad, representing Danny Gaekwad Developments & Investments Florida, expressed a willingness to acquire 26 percent of REL’s outstanding share capital through an Open Offer. Gaekwad argued that their offer of ₹275 per share provides a fair and reasonable exit opportunity for public shareholders in accordance with SEBI Takeover Regulations.

The letter raised concerns about the Burmans’ Open Offer, stating that it undervalues REL and fails to disclose how they intend to comply with RBI-mandated conditions on the consolidation of NBFCs within Religare and Burman groups. Gaekwad also questioned the accuracy of the Burmans’ claim that RBI approval for the offer was unconditional.

SEBI approved the Burmans’ Open Offer on December 20, 2024, following RBI’s conditional approval on December 9, 2024. The independent directors of Religare Enterprises recently advised public shareholders to carefully evaluate their options, noting that the Burman family’s offer price of ₹235 per share is low.

The competing offer from Danny Gaekwad at ₹275 per share adds a new dimension to the REL takeover saga, offering shareholders an alternative to consider. It remains to be seen how this development will impact the ongoing acquisition process and the choices available to REL shareholders.

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article Ricky Ponting advocates for Sam Konstas’ inclusion in playing XI against Sri Lanka Ricky Ponting Supports Sam Konstas for Playing XI Against Sri Lanka
Next Article Dating Apps Promise to Remain a Rare Haven Following Trump’s Executive Order Dating Apps Vow to Stay Safe Spaces After Trump’s Executive Order
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Ajmera Realty reports 48% jump in H1 presales, eyes ₹12,000 crore Wadala pipeline

Ajmera Realty reports 48% jump in H1 presales, eyes ₹12,000 crore Wadala pipeline Rewrite this headline into a unique, engaging, SEO-friendly news title. Use only English. Maximum 12 words. Output only the new title.

November 7, 2025
Left Unity reclaims JNUSU central panel, wipes out ABVP’s sole seat

Left Unity Triumphs in JNUSU, Displaces ABVP’s Sole Seat

November 7, 2025
Asian shares sink after losses for Big Tech pull US stocks lower

Today’s Stock Pick: Buy Can Fin Homes at ₹877 – November 7, 2025

November 7, 2025
SEBI expands anchor investor quota in IPOs to 40% to broaden institutional investors participation

SEBI Boosts IPO Anchor Investor Quota to 40% for Greater Institutional Involvement

November 7, 2025
Broker’s call: Sun Pharma (Add)

Sun Pharma: Strategic Buy Recommendation for Continued Growth

November 7, 2025
Broker’s call: State Bank of India (Buy)

State Bank of India: Analyst Recommends ‘Buy’ for Investors

November 7, 2025

You Might Also Like

India's forex reserves extend decline, stand at 10% below peak
Economy

India’s Forex Reserves Drop, 10% Below Peak Levels

2 Min Read
Mid-, small-caps slide to continue
Economy

Sensex, Nifty flat with positive bias; Bharti Airtel, M&M lead gains.

3 Min Read
Bihar polls: NDA announces seat-sharing deal; BJP, JD(U) to contest 101 seats each
Nation

Bihar Elections: NDA Finalizes Seat Sharing—BJP and JD(U) Choose 101 Seats Each

2 Min Read
Padma Vibhushan for ex-CJI Khehar, Suzuki, violinist L Subramaniam
Nation

Padma Vibhushan Honors Ex-CJI Khehar, Suzuki, and Violinist L Subramaniam

6 Min Read
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek

Welcome to IndiaNewsWeek, your reliable source for all the essential news and insights from across the nation. Our mission is to provide timely and accurate news that reflects the diverse perspectives and voices within India.

  • Home
  • Nation News
  • Economy News
  • Politics News
  • Sports News
  • Technology
  • Entertainment
  • International
  • Auto News
  • Bookmarks
  • About us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
  • About us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service

© 2024 All Rights Reserved | Powered by India News Week

Welcome Back!

Sign in to your account

Lost your password?